• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺血性心脏病的最新进展

Recent advances in ischaemic heart disease.

作者信息

Cusack M, Redwood S, Coltart J

机构信息

Cardiothoracic Unit, St Thomas' Hospital, London SE1 7EH, UK.

出版信息

Postgrad Med J. 2000 Sep;76(899):542-6. doi: 10.1136/pmj.76.899.542.

DOI:10.1136/pmj.76.899.542
PMID:10964115
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1741717/
Abstract

There continue to be important developments in the understanding of the pathogenesis of coronary artery disease. Advances have also been made in both the medical and interventional management of patients with ischaemic heart disease. This review has, however, not focused on the wider developments that have occurred in the area of percutaneous intervention. The vast array of new stent designs and other interventional devices have had a considerable impact on the treatment of obstructive coronary disease. In addition it is likely that further developments will be seen in areas such as intracoronary radiotherapy to reduce restenosis after PTCA and in gene therapy to promote angiogenesis in ischaemic myocardium. Both of which will be discussed in a future review of this area.

摘要

在冠心病发病机制的理解方面不断有重要进展。在缺血性心脏病患者的药物和介入治疗管理上也取得了进步。然而,本综述未聚焦于经皮介入领域所发生的更广泛进展。大量新型支架设计及其他介入装置对阻塞性冠状动脉疾病的治疗产生了相当大的影响。此外,在冠状动脉内放射治疗以减少经皮冠状动脉腔内血管成形术(PTCA)后的再狭窄以及基因治疗以促进缺血心肌血管生成等领域可能会有进一步发展。这两方面都将在该领域未来的综述中进行讨论。

相似文献

1
Recent advances in ischaemic heart disease.缺血性心脏病的最新进展
Postgrad Med J. 2000 Sep;76(899):542-6. doi: 10.1136/pmj.76.899.542.
2
Abciximab: an updated review of its therapeutic use in patients with ischaemic heart disease undergoing percutaneous coronary revascularisation.阿昔单抗:对其在接受经皮冠状动脉血运重建术的缺血性心脏病患者中治疗应用的最新综述。
Drugs. 2003;63(11):1121-63. doi: 10.2165/00003495-200363110-00014.
3
Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review.冠状动脉支架治疗缺血性心脏病:一项快速系统评价
Health Technol Assess. 2000;4(23):1-153.
4
The complementary use of glycoprotein IIb/IIIa inhibitors and drug-eluting stents in contemporary percutaneous coronary intervention.糖蛋白IIb/IIIa抑制剂与药物洗脱支架在当代经皮冠状动脉介入治疗中的联合应用。
J Invasive Cardiol. 2002 Dec;14 Suppl E:36E-46E; quiz 47E.
5
Spotlight on abciximab in patients with ischemic heart disease undergoing percutaneous coronary revascularization.聚焦于接受经皮冠状动脉血运重建术的缺血性心脏病患者使用阿昔单抗的情况。
Am J Cardiovasc Drugs. 2003;3(5):381-6. doi: 10.2165/00129784-200303050-00011.
6
The treatment of coronary heart disease: an update. Part 4: Acute ischaemic coronary syndromes.冠心病的治疗:最新进展。第4部分:急性缺血性冠状动脉综合征。
Curr Med Res Opin. 2001;17(1):38-40.
7
[Percutaneous coronary intervention].
Orv Hetil. 2005 Mar 27;146(13):587-93.
8
Impact of platelet glycoprotein IIb/IIIa Inhibition on the paclitaxel-eluting stent in patients with stable or unstable angina pectoris or provocable myocardial ischemia (a TAXUS IV substudy).血小板糖蛋白IIb/IIIa抑制对稳定型或不稳定型心绞痛或可诱发性心肌缺血患者紫杉醇洗脱支架的影响(TAXUS IV子研究)
Am J Cardiol. 2005 Aug 15;96(4):500-5. doi: 10.1016/j.amjcard.2005.04.009.
9
Early and late ischemic complications of PTCA.经皮冠状动脉腔内血管成形术的早期和晚期缺血性并发症。
J Invasive Cardiol. 1994;6 Suppl A:3A-12A, discussion 43A-45A.
10
Benefit of bolus-only platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: insights from the very early outcomes in the Evaluation of 7E3 for the Prevention of Ischemic Complications (EPIC) trial.
Am Heart J. 2006 Nov;152(5):876-81. doi: 10.1016/j.ahj.2006.04.035.

引用本文的文献

1
Biological Activities of Paeonol in Cardiovascular Diseases: A Review.丹皮酚在心血管疾病中的生物学活性:综述。
Molecules. 2021 Aug 17;26(16):4976. doi: 10.3390/molecules26164976.

本文引用的文献

1
Cardiac sympathetic denervation after transmyocardial laser revascularization.经心肌激光血运重建术后的心脏交感神经去神经支配
Circulation. 1999 Jul 13;100(2):135-40. doi: 10.1161/01.cir.100.2.135.
2
Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators.阿昔单抗可促进溶栓的速度和程度:心肌梗死溶栓治疗(TIMI)14试验的结果。TIMI 14研究人员。
Circulation. 1999 Jun 1;99(21):2720-32. doi: 10.1161/01.cir.99.21.2720.
3
C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992.C反应蛋白是一种炎症敏感标志物,可预测最初健康的中年男性未来患冠心病的风险:1984年至1992年奥格斯堡心血管疾病监测趋势和决定因素(MONICA)队列研究的结果。
Circulation. 1999 Jan 19;99(2):237-42. doi: 10.1161/01.cir.99.2.237.
4
Inflammation of the atherosclerotic cap and shoulder of the plaque is a common and locally observed feature in unruptured plaques of femoral and coronary arteries.
Arterioscler Thromb Vasc Biol. 1999 Jan;19(1):54-8. doi: 10.1161/01.atv.19.1.54.
5
Can C reactive protein or troponins T and I predict outcome in patients with intractable unstable angina?C反应蛋白或肌钙蛋白T及I能否预测难治性不稳定型心绞痛患者的预后?
Heart. 1998 Jul;80(1):23-7.
6
Initial results of laser-based percutaneous myocardial revascularization for angina pectoris.基于激光的经皮心肌血运重建术治疗心绞痛的初步结果。
Am J Cardiol. 1998 Sep 1;82(5):659-62, A6. doi: 10.1016/s0002-9149(98)00384-1.
7
Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators.与保守治疗策略相比,随机分配接受侵入性治疗的急性非Q波心肌梗死患者的预后。退伍军人事务部非Q波心肌梗死住院治疗策略(VANQWISH)试验研究人员。
N Engl J Med. 1998 Jun 18;338(25):1785-92. doi: 10.1056/NEJM199806183382501.
8
C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction.C反应蛋白是急性冠状动脉综合征患者死亡率的有力预测指标,无论单独还是与肌钙蛋白T联合使用均如此:心肌梗死溶栓治疗(TIMI)11A亚研究。
J Am Coll Cardiol. 1998 Jun;31(7):1460-5. doi: 10.1016/s0735-1097(98)00136-3.
9
C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction.C反应蛋白可增强总胆固醇和高密度脂蛋白胆固醇在预测首次心肌梗死风险方面的预测价值。
Circulation. 1998 May 26;97(20):2007-11. doi: 10.1161/01.cir.97.20.2007.
10
A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina.阿司匹林联合替罗非班与阿司匹林联合肝素治疗不稳定型心绞痛的比较。
N Engl J Med. 1998 May 21;338(21):1498-505. doi: 10.1056/NEJM199805213382103.